Yuting Yi

1.4k total citations
54 papers, 631 citations indexed

About

Yuting Yi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yuting Yi has authored 54 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 18 papers in Oncology and 17 papers in Cancer Research. Recurrent topics in Yuting Yi's work include Cancer Genomics and Diagnostics (12 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Immunotherapy and Immune Responses (5 papers). Yuting Yi is often cited by papers focused on Cancer Genomics and Diagnostics (12 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Immunotherapy and Immune Responses (5 papers). Yuting Yi collaborates with scholars based in China, United States and France. Yuting Yi's co-authors include Yanfang Guan, Ling Yang, Lianru Zhang, Xiaoping Zhang, Zhonghui Zheng, Siyang Song, Yifei Sun, Dan Jiang, Asan and Xin Yi and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Yuting Yi

51 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuting Yi China 14 252 192 155 114 106 54 631
Tingting Zhao China 17 278 1.1× 224 1.2× 177 1.1× 143 1.3× 46 0.4× 35 672
Magdy Sayed Aly Egypt 14 235 0.9× 106 0.6× 91 0.6× 136 1.2× 86 0.8× 44 644
Peter Schirmacher Germany 11 390 1.5× 320 1.7× 188 1.2× 241 2.1× 58 0.5× 21 849
Huan-Ming Hsu Taiwan 16 393 1.6× 207 1.1× 172 1.1× 73 0.6× 99 0.9× 32 718
Antoine L’Hermitte United States 8 391 1.6× 204 1.1× 151 1.0× 105 0.9× 38 0.4× 10 672
Yuji Hayashi Japan 18 217 0.9× 237 1.2× 109 0.7× 51 0.4× 48 0.5× 57 793
Jong‐Sun Choi South Korea 14 322 1.3× 122 0.6× 189 1.2× 74 0.6× 64 0.6× 20 565
Vijayalakshmi Ananthanarayanan United States 15 326 1.3× 150 0.8× 205 1.3× 239 2.1× 77 0.7× 42 755
Anand Rajan United States 14 228 0.9× 125 0.7× 119 0.8× 57 0.5× 39 0.4× 49 548

Countries citing papers authored by Yuting Yi

Since Specialization
Citations

This map shows the geographic impact of Yuting Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuting Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuting Yi more than expected).

Fields of papers citing papers by Yuting Yi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuting Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuting Yi. The network helps show where Yuting Yi may publish in the future.

Co-authorship network of co-authors of Yuting Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Yuting Yi. A scholar is included among the top collaborators of Yuting Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuting Yi. Yuting Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Pan, Yuting Yi, Yuan Li, et al.. (2025). Isolation, structural characterization, and antiviral activity of a sulfated polysaccharide (LJP-1) from Laminaria japonica. International Journal of Biological Macromolecules. 311(Pt 3). 143943–143943. 2 indexed citations
2.
Wang, Muyang, Yuting Yi, Qiuju Huang, et al.. (2024). Fufang Luohanguo Qingfei granules reduces influenza virus susceptibility via MAVS-dependent type I interferon antiviral signaling. Journal of Ethnopharmacology. 324. 117780–117780. 4 indexed citations
3.
Liu, Yuxuan, Wenwu Liu, Chenghui Cao, et al.. (2024). Association of neutrophil-to-lymphocyte ratio with all-cause and cardiovascular mortality in CVD patients with diabetes or pre-diabetes. Scientific Reports. 14(1). 24324–24324. 8 indexed citations
5.
Yi, Yuting, et al.. (2024). Abstract 4142394: HDL/ApoA1 inhibits macrophage ferroptosis via upregulating NRF2/SLC7A11/GSH pathway. Circulation. 150(Suppl_1). 1 indexed citations
6.
Lin, Jing, Jun Liu, Yingqian Zhang, et al.. (2022). An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy. Frontiers in Immunology. 13. 1022598–1022598. 7 indexed citations
7.
Zheng, Hong, Tong Shu, Shan Zhu, et al.. (2021). Construction and Validation of a Platinum Sensitivity Predictive Model With Multiple Genomic Variations for Epithelial Ovarian Cancer. Frontiers in Oncology. 11. 725264–725264. 9 indexed citations
8.
Wang, Jing, Ruiyu Li, Junjie Li, et al.. (2021). Comprehensive analysis of oncogenic fusions in mismatch repair deficient colorectal carcinomas by sequential DNA and RNA next generation sequencing. Journal of Translational Medicine. 19(1). 433–433. 11 indexed citations
9.
Qin, Yan, Shiyu Jiang, Peng Liu, et al.. (2020). <p>Characteristics and Management of <em>TP53</em>-Mutated Diffuse Large B-Cell Lymphoma Patients</p>. Cancer Management and Research. Volume 12. 11515–11522. 10 indexed citations
10.
Zhuo, Minglei, Zhen Liang, Yuting Yi, et al.. (2020). Analysis of MET kinase domain rearrangement in NSCLC. Lung Cancer. 145. 140–143. 12 indexed citations
12.
Qu, Shoufang, Qiong Chen, Yuting Yi, et al.. (2019). A Reference System for BRCA Mutation Detection Based on Next-Generation Sequencing in the Chinese Population. Journal of Molecular Diagnostics. 21(4). 677–686. 5 indexed citations
13.
Chen, Xiaofei, et al.. (2018). Selection, purification, and characterization of a HER2-targeting soluble designed ankyrin repeat protein by E. coli surface display using HER2-positive melanoma cells. Preparative Biochemistry & Biotechnology. 48(2). 144–150. 3 indexed citations
14.
Yuan, Gang, Qiuli Liu, Dali Tong, et al.. (2018). A retrospective case study of sunitinib treatment in three patients with Von Hippel-Lindau disease. Cancer Biology & Therapy. 19(9). 766–772. 10 indexed citations
15.
Liu, Qiuli, Dali Tong, Gaolei Liu, et al.. (2017). HIF2Agermline–mutation-induced polycythemia in a patient with VHL-associated renal-cell carcinoma. Cancer Biology & Therapy. 18(12). 944–947. 11 indexed citations
16.
Lv, Xiaoxing, Meiru Zhao, Yuting Yi, et al.. (2017). Detection of Rare Mutations in CtDNA Using Next Generation Sequencing. Journal of Visualized Experiments. 19 indexed citations
17.
Yi, Yuting, Hong Yao, Huamei Hu, et al.. (2016). Targeted next-generation sequencing identification of mutations in patients with disorders of sex development. BMC Medical Genetics. 17(1). 23–23. 51 indexed citations
18.
19.
Peng, Lin, Yuting Yi, Miaomiao Wang, et al.. (2014). Heat shock protein 90 inhibitor mycoepoxydiene modulates kinase signaling in cervical cancer cells and inhibits in-vivo tumor growth. Anti-Cancer Drugs. 26(1). 25–34. 9 indexed citations
20.
Zhang, Lianru, Yuting Yi, Yifei Sun, et al.. (2011). Hsp90 interacts with AMPK and mediates acetyl-CoA carboxylase phosphorylation. Cellular Signalling. 24(4). 859–865. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026